Federated Hermes
IMVT icon

Federated Hermes’s Immunovant IMVT Stock Holding History

Federated Hermes’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-154,192
Closed -$4.4M – 2132
2024
Q3 		$4.4M Buy
+154,192
New +$4.55M 0.01% 748
2024
Q1 		– Sell
-2,979
Closed -$126K – 2081
2023
Q4 		$126K Sell
2,979
-356,609
-99% -$13.1M ﹤0.01% 1569
2023
Q3 		$13.8M Buy
359,588
+310,163
+628% +$7.01M 0.04% 459
2023
Q2 		$938K Sell
49,425
-3,067
-6% -$57.2K ﹤0.01% 1157
2023
Q1 		$814K Buy
52,492
+9,924
+23% +$172K ﹤0.01% 1234
2022
Q4 		$756K Buy
42,568
+32,708
+332% +$412K ﹤0.01% 1226
2022
Q3 		$55K Sell
9,860
-1,872,491
-99% -$9.15M ﹤0.01% 1661
2022
Q2 		$7.34M Sell
1,882,351
-21,543
-1% -$93.1K 0.02% 614
2022
Q1 		$10.5M Buy
1,903,894
+1,404,404
+281% +$8.75M 0.02% 592
2021
Q4 		$4.26M Buy
499,490
+486,456
+3,732% +$4.02M 0.01% 859
2021
Q3 		$113K Buy
+13,034
New +$118K ﹤0.01% 1756
2021
Q1 		– Sell
-171,059
Closed -$7.9M – 2283
2020
Q4 		$7.9M Buy
171,059
+149,193
+682% +$6.9M 0.02% 699
2020
Q3 		$769K Buy
+21,866
New +$658K ﹤0.01% 1350

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes's IMVT Position: Q4 2024 in Review

Federated Hermes sold out of Immunovant (IMVT) in Q4 2024, closing a stake of 154,192 shares — an estimated $4.4M sold.

Federated Hermes first reported a position in IMVT in Q3 2020 and held it in 13 quarters. The position peaked at $13.8M in Q3 2023. 186 funds tracked by Wall St. Rank hold IMVT as of Q4 2024.

  • Federated Hermes reported no remaining Immunovant position as of Q4 2024 after selling out during the quarter.
  • Federated Hermes sold 154,192 Immunovant shares in Q4 2024, an estimated $4.4M.
  • Federated Hermes first reported a position in Immunovant in Q3 2020 and held it in 13 quarters.
  • Federated Hermes's Immunovant position peaked at $13.8M in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q4 2024.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.